Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
AbbVie
3163
AbbVie
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
AbbVie's official global Twitter feed featuring news and updates managed by our global newsroom. Review our Twitter guidelines here on our site
Suggest edits
Founded
2013
Follow us
Featured on
Also headquartered in Chicago
Motorola
Boeing
Dyson
Walgreens
Internet Retailer
United Airlines
Signal
CBOE
Lightspeed
Thoma Bravo
Companies in the same industry
TCD Pharma
Helix Biopharma Corp (HBPCF)
F2G
Fusion Pharmaceuticals
Hazel Technologies
ViraCyte
Pherecydes Pharma
Creative Diagnostics
Labii Inc.
Spiral Therapeutics
Alexa global traffic share
Twitter followers
Overview
Investments
4
Acquisitions
1
Apps
5
Add info
Team Size
10000+
Employees
I work here
Location
Chicago
,
United States
Headquarters
Explore Chicago
Xconomy
Allergan Offloads Two Drugs to Secure Approval of Merger With AbbVie
SiliconRepublic
Sale of IBD drug stands in the way of $63bn AbbVie takeover of Allergan
VCCircle
Alkem Labs to acquire API assets from American firm AbbVie
Xconomy
Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer
Reuters Top News
FTC requests AbbVie, Allergan for more information on $63 billion deal
Reuters Top News
Consumer groups, unions urge caution on $63 billion AbbVie deal for...
Xconomy
Bio Roundup: Cholesterol Check, J&J's Opioid Hit, AbbVie's Flop & More
Xconomy
$5.8B for Nothing: AbbVie Shelves Stemcentryx Drug After Latest Flop
Reuters Top News
FDA flags risks from AbbVie, Gilead, Merck hepatitis C drugs to...
Reuters Top News
AbbVie prices new rheumatoid arthritis drug at $59,000 a year
FinSMEs
AbbVie Acquires Mavupharma
MedCity News
AbbVie to buy Allergan for $63B
Xconomy
,
Reuters Top News
AbbVie to Pay $63B for Allergan to Prepare for Life Without Humira
Fast Company
Botox boom: Allergan stock skyrockets on news of AbbVie acquisition
MedCity News
AbbVie, Roche's Venclexta stumbles amid patient deaths in multiple myeloma trial
Forbes
Why Abbvie May Have A Tough Time Defending Humira's Price Before Congress
MedCity News
,
Xconomy
AbbVie wades into crowded multiple myeloma market
Xconomy
Tizona Lands $105M from AbbVie in Cancer Drug R&D Alliance
Xconomy
AbbVie Commits $100M to Morphic in Fibrosis Drug R&D Alliance
Bloomberg
AbbVie Must Escape the Shadow of Humira's Decline
Earnings
Health
